Gregory Demopulos
Vorstandsvorsitzender bei OMEROS CORPORATION
Vermögen: 6 Mio $ am 30.04.2024
Aktive Positionen von Gregory Demopulos
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OMEROS CORPORATION | Vorstandsvorsitzender | 16.06.1994 | - |
Vorsitzender | 16.06.1994 | - | |
Gründer | 05.10.2009 | - | |
Präsident | 16.06.1994 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 16.06.1994 | 03.05.2010 | |
Finanzdirektor/CFO | 03.05.2010 | 17.10.2013 | |
Treasurer | 03.05.2010 | 19.06.2014 | |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Direktor/Vorstandsmitglied | - | - |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - | - |
Smead Funds Trust | Direktor/Vorstandsmitglied | - | - |
Northwest NeuroNeighborhood | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Gregory Demopulos
Ausbildung von Gregory Demopulos
Stanford University | Undergraduate Degree |
Stanford University School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Israel | 2 |
Operativ
Director/Board Member | 4 |
Chief Executive Officer | 1 |
Chairman | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
OMEROS CORPORATION | Health Technology |
Private Unternehmen | 4 |
---|---|
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Electronic Technology |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Health Technology |
Smead Funds Trust | Miscellaneous |
Northwest NeuroNeighborhood |
- Börse
- Insiders
- Gregory Demopulos
- Erfahrung